My Treatment Approach: Graft vs Host Disease : Episode 9
Tailored Conditioning Regimens for Patients with GVHD Receiving Allogeneic Transplant
Pashna Munshi, MD, details how age and risk factors into her choice of conditioning regimen for patients with GVHD receiving allogeneic transplant.
EP: 1.Patient Profile Presentation: A 60-Year-Old Man with Graft-Versus-Host Disease (GVHD)
EP: 2.Staging of Chronic GVHD
EP: 3.First-Line Treatment Options for Patients with Chronic GVHD
EP: 4.Patient Profile Presentation: A 67-Year-Old Woman with GVHD
EP: 5.Investigational Systemic Treatment Options for GVHD
EP: 6.Treatment Sequencing and Future of GVHD
EP: 7.Patient Profile Presentation: A 44-Year-Old Woman With Acute Myeloid Leukemia and Graft-Versus-Host Disease (GVHD)
EP: 8.Indications for Allogeneic Stem Cell Transplantation in the Treatment of Myeloid Malignancies
Now Viewing
EP: 9.Tailored Conditioning Regimens for Patients with GVHD Receiving Allogeneic Transplant
EP: 10.Currently Available Options for GVHD Prophylaxis
EP: 11.Comparing Acute and Chronic GVHD
EP: 12.Available Frontline Treatment Options for Patients With Acute GVHD
EP: 13.Current Treatment Options for Patients with Steroid-Refractory Acute GVHD
Related Videos
